Implantable Sensor Market Overview and Growth by 2031

The Implantable Sensor Market size was estimated to be US$ 4.19 billion in 2023 and is expected to reach US$ 17.32 billion by 2031.

It is estimated to record a CAGR of 11.1% till 2031. Development of novel speech therapies, alternative methods of communication, increased newborn hearing screenings, and use of artificial intelligence in speech therapies are likely to remain key implantable sensor Market trends.

Implantable Sensor Market Analysis

Implantable sensors are small medical devices put inside the body to observe the various body physiological parameters, such as temperature, pressure, glucose level, or drug concentration. Such products have received tremendous attention in the healthcare industry. The device is able to provide real-time data to healthcare specialists for better management of chronic medical conditions or pre/post-surgery monitoring. The increasing prevalence of chronic medical conditions is expected to favor the development of new products and drive the implantable sensor market.  

Implantable Sensor Market Overview

The growth of the market is attributed to some key driving factors, such as increasing chronic disease prevalence and growing adoption of mobile healthcare technologies. However, the low rate of adoption in emerging countries is a major factor hindering the market growth. The global implantable sensor market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the US is the largest market for implantable sensors. The growth of the region is attributed to the presence of key market players and growing product developments. In addition, continuous product developments are further expected to stimulate the growth of the implantable sensor market in North America. The Asia Pacific region is expected to account for the fastest growth in the implantable sensor market.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Implantable Sensor Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Implantable Sensor Market Drivers and Opportunities

Growing Adoption of Mobile Healthcare Technologies to Favor Market

The growing adoption of mobile healthcare technologies is revolutionizing healthcare delivery by providing convenient access to medical information, monitoring, and communication tools through smartphones, wearable medical devices, and others. The trend is empowering individuals to take charge of health, facilitating remote patient monitoring, improving access to healthcare services, and improving the overall patient experience. Chronic disorders like diabetes, blood pressure, and arrhythmia detection are major drivers of the global implantable sensor market share.

Government Support to Medical Technologies – An Opportunity in Implantable Sensor Market

Investments in medical research and development activities are on the rise across the world. As per the US Investments in Medical and Health Research and Development 2016—2020 report, investments in the US for medical and health R&D were increased by US$ 48.5 billion or 42% from 2016 to 2020, and the federal investments were increased by US$ 21.4 billion or 53.5% from 2016 to 2020. The investment in medical technology also increased by 36.49% from 2016 to 2020. Thus, government support in advancing medical technologies is seen to leave a positive impact on the implantable sensor market, as it has an opportunity for medical device manufacturers.

Implantable Sensor Market Report Segmentation Analysis

Key segments that contributed to the derivation of the implantable sensor market analysis are type, application, and end user.

• Based on type, the implantable sensor market is divided into glucose sensors, temperature sensors, oxygen sensors, pressure sensors, and others. The software segment held a larger market share in 2023. The glucose sensor segment held the largest share of the market in 2023, whereas the oxygen sensor segment is anticipated to register the highest CAGR in the market during the forecast period.
• By application, the market is segmented into medical diagnostic, clinical therapy, personal healthcare, and imaging. The medical diagnostic segment held the largest share of the market in 2023; however, the personal healthcare segment is expected to register the highest CAGR in the market during 2024–2031.
• In terms of end users, the market is bifurcated into hospitals, clinics, and diagnostic centres. The hospital segment dominated the market in 2023, and it is estimated to register the highest CAGR in the market during the forecast period.

Implantable Sensor Market Share Analysis by Geography

The geographic scope of the implantable sensor market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has dominated the implantable sensor market. As per the American Diabetes Association, nearly 38.4 million Americans, or approx. 11.6% of the population will be living with diabetes disorder in 2021, Out of which the elderly population or those 65 and older hold the majority of the share. Due to rising incidences of diabetes in the region, North America held the largest share in 2022. An inclination toward technically advanced products and the presence of global market players are factors contributing to the dominance of the North America implantable sensor market. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.  

Implantable Sensor Market Regional Insights

The regional trends and factors influencing the Implantable Sensor Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Implantable Sensor Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Implantable Sensor Market Report Scope

Implantable Sensor Market Players Density: Understanding Its Impact on Business Dynamics

The Implantable Sensor Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Implantable Sensor Market are:

1. Analog Devices, Inc.
2. DEXCOM, INC.
3. Glusense Ltd.
4. Honeywell International Inc.
5. Medtronic
6. NXP SEMICONDUCTORS N.V.

Disclaimer: The companies listed above are not ranked in any particular order.

Implantable Sensor Market News and Recent Developments

The Implantable Sensor Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for implantable sensors and strategies:

• In December 2023, Medstar became the first company in the world to implant Cordella sensor implant for advanced heart failure. The sensor remotely sends the patient’s pulmonary artery pressure via a wireless microelectromechanical sensor to the team of doctors. With this real-time data, doctors can proactively adjust medications and therapies with the goal of reducing HF hospitalizations. (Source: MedStar Health, Press Release, 2024)
• In Feb 2022, Ascensia Diabetes Care, a global diabetes care company, announced that its partner Senseonics Holdings, Inc. has received approval from the US Food and Drug Administration (FDA) for the next-generation Eversense® E3 Continuous Glucose Monitoring (CGM) System. Ascensia plans to make the Eversense E3 sensor, which can be used for up to 6 months, available to patients in the US (Source: Ascensia Diabetes Care Holdings AG., Senseonics, Inc. Press Release/Company Website/Newsletter, 2024)

Implantable Sensor Market Report Coverage and Deliverables

The “Implantable Sensor Market Size and Forecast (2024–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles